| Beta | S. E | Wald | P | Odds ratio | 95% C.I.for EXP(B) | ||
---|---|---|---|---|---|---|---|---|
Lower | Upper | |||||||
Poor diabetic control | 2.323 | 0.557 | 17.415 | 0.001* | 10.207 | 3.428 | 30.392 | |
Malignancy | 1.183 | 0.671 | 3.104 | 0.078 | 3.264 | 0.875 | 12.171 | |
Chronic obstructive pulmonary disease | -1.803 | 0.960 | 3.526 | 0.060 | 0.165 | 0.025 | 0.982 | |
Chronic liver disease | 0.881 | 0.992 | 0.788 | 0.375 | 2.413 | 0.345 | 16.858 | |
Organ transplantation | 0.617 | 0.881 | 0.490 | 0.484 | 1.853 | 0.330 | 10.412 | |
Multiple comorbidities | 2.115 | 0.846 | 12.657 | 0.004* | 4.574 | 1.834 | 14.883 | |
APACHE II Score | 0.699 | 1.031 | 0.459 | 0.498 | 2.011 | 0.266 | 15.183 | |
SOFA Score | 0.283 | 0.670 | 0.178 | 0.673 | 1.327 | 0.357 | 4.937 | |
Prolonged steroid use | 2.646 | 0.465 | 32.347 | 0.001* | 14.1 | 5.665 | 35.097 | |
Use of high dose steroids | 2.648 | 0.856 | 16.657 | 0.001* | 14.574 | 5.834 | 33.784 | |
Use of tocilizumab | 0.701 | 0.811 | 0.645 | 0.42 | 2.015 | 0.365 | 11.142 | |
Antibiotic combination | 1.610 | 1.184 | 1.850 | 0.174 | 5.004 | 0.492 | 50.947 | |
Noninvasive MV | 1.758 | 0.874 | 4.784 | 0.06 | 6.351 | 1.634 | 15.875 | |
Invasive MV | 0.287 | 0.641 | 0.200 | 0.654 | 1.332 | 0.380 | 4.676 | |
Central venous line | 1.136 | 0.752 | 2.283 | 0.051 | 3.115 | 0.714 | 13.598 | |
Parenteral nutrition | 1.798 | 0.934 | 5.729 | 0.093 | 4.221 | 1.365 | 11.142 | |
Duration of antibiotic use | 0.701 | 0.872 | 0.645 | 0.422 | 2.015 | 0.365 | 11.142 | |
Length of hospital stay | 2.401 | 1.257 | 3.648 | 0.056 | 11.032 | 0.939 | 12.953 | |
CRP | 0.633 | 0.601 | 1.109 | 0.292 | 1.883 | 0.580 | 6.117 | |
D-dimer | 1.136 | 0.752 | 2.283 | 0.131 | 3.115 | 0.714 | 13.598 | |
Ferritin | 0.118 | 0.699 | 0.028 | 0.866 | 1.125 | 0.286 | 4.430 |